![Philip Frost](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philip Frost
Oprichter bij Primrose Therapeutics, Inc.
Actieve functies van Philip Frost
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Calesca Pharmaceuticals, Inc. | President | - | - |
Primrose Therapeutics, Inc. | Hoofd Techniek/Wetenschap/O&O | 14-01-2011 | - |
Oprichter | 21-03-2011 | - |
Loopbaan van Philip Frost
Eerdere bekende functies van Philip Frost
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Directeur/Bestuurslid | 28-11-2007 | 20-11-2012 |
Independent Dir/Board Member | 28-11-2007 | 20-11-2012 | |
Innovive Pharmaceuticals, Inc.
![]() Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Directeur/Bestuurslid | 11-10-2010 | 11-10-2010 |
ImClone LLC
![]() ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Algemeen Directeur | 01-11-2005 | 01-01-2007 |
Hoofd Techniek/Wetenschap/O&O | 01-03-2005 | 01-01-2007 | |
The University of Texas M.D. Anderson Cancer Center
![]() The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
Avalon Pharmaceuticals, Inc.
![]() Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Directeur/Bestuurslid | 19-08-2009 | - |
Wyeth Corp.
![]() Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - | - |
Opleiding van Philip Frost
State University of New York at Buffalo | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 9 |
Verenigd Koninkrijk | 2 |
Operationeel
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 8 |
---|---|
Wyeth Corp.
![]() Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Calesca Pharmaceuticals, Inc. | |
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Avalon Pharmaceuticals, Inc.
![]() Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Health Technology |
Primrose Therapeutics, Inc. | |
The University of Texas M.D. Anderson Cancer Center
![]() The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
Innovive Pharmaceuticals, Inc.
![]() Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
ImClone LLC
![]() ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
- Beurs
- Insiders
- Philip Frost
- Ervaring